The emergence of genetic medicines, the convergence of information technology and biotechnology, and the growing ubiquity of artificial intelligence represents some of the transformative forces reshaping healthcare in the years ahead. The BioFuture conference, which will be held in New York City October 4 through 6, brings together innovators and investors to exchange ideas, discuss trends, and do business. We spoke to event organizer Sara Demy, founder and CEO of Demy-Colton, about BioFuture, how innovative technologies are transforming healthcare, and why this is unlike other biotech conferences.
By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.